CME Group (CME) Stock Buyback History
TTM buyback yield 0.75% · Shareholder yield (TTM) 0.75%.
CME
TTM buyback yield
0.75%
Shareholder yield (TTM)
0.75%
5Y share count change
0.5%
TTM buyback spend
$796.60M
SBC coverage (TTM)
8.35x
YoY change in spend
+706.4%
5Y CAGR of spend
+45.1%
Peak year (2007)
$949.34M
Cumulative spend
$2.42B
TTM metrics calculated from the four most recent reported quarters, ending (reported ).
Key takeaways
- CME Group (CME) repurchased about $796.60M of stock over the trailing twelve months.
- Diluted share count is roughly flat (0.5%) over the last ~5 fiscal years — buybacks are offsetting dilution but not shrinking the float.
- TTM buyback ÷ stock-based-comp ratio of 8.35× — repurchases more than cover SBC dilution.
- Cash buyback spend has compounded at +45.1% per year over the latest 5-year window.
- TTM repurchases used about 299% of free cash flow remaining after dividends.
Buyback context per fiscal year
Annual repurchases alongside stock-based compensation, diluted share count and the year-over-year change — useful for SBC-coverage and dilution-offset reading at a glance.
| Year | Buybacks | SBC | Net | Shares (dil.) | YoY shares | Buyback yield |
|---|---|---|---|---|---|---|
| 2025 | $266.10M | $94.80M | $171.30M | 0.36B | 0.1% | 0.27% |
| 2024 | $33.00M | $89.50M | −$56.50M | 0.36B | 0.1% | 0.04% |
| 2023 | $21.40M | $82.90M | −$61.50M | 0.36B | 0.1% | 0.03% |
| 2022 | $24.80M | $84.30M | −$59.50M | 0.36B | 0.1% | 0.04% |
| 2021 | $0.00 | $75.20M | −$75.20M | 0.36B | 0.1% | — |
| 2020 | $41.40M | $96.00M | −$54.60M | 0.36B | 0.1% | 0.06% |
| 2019 | $36.80M | $73.10M | −$36.30M | 0.36B | 4.2% | 0.05% |
| 2018 | $0.00 | $96.50M | −$96.50M | 0.34B | 1.0% | — |
| 2017 | $0.00 | $58.00M | −$58.00M | 0.34B | 0.4% | — |
| 2016 | $0.00 | $66.20M | −$66.20M | 0.34B | 0.3% | — |
| 2015 | $0.00 | $60.80M | −$60.80M | 0.34B | 0.5% | — |
| 2014 | $0.00 | $54.80M | −$54.80M | 0.34B | 0.5% | — |
| 2013 | $0.00 | $54.40M | −$54.40M | 0.33B | 0.6% | — |
| 2012 | $0.00 | $61.40M | −$61.40M | 0.33B | -0.4% | — |
| 2011 | $220.40M | $51.30M | $169.10M | 0.33B | 0.4% | 1.37% |
| 2010 | $575.30M | $40.90M | $534.40M | 0.33B | -0.1% | 2.68% |
| 2009 | $27.00M | $33.40M | −$6.40M | 0.33B | 12.9% | 0.12% |
| 2008 | $224.03M | $0.00 | $224.03M | 0.29B | 33.7% | 1.80% |
| 2007 | $949.34M | $22.85M | $926.49M | 0.22B | 25.6% | 2.90% |
| 2006 | $0.00 | $16.36M | −$16.36M | 0.18B | 0.8% | — |
| 2005 | $0.00 | $0.00 | $0.00 | 0.17B | 1.2% | — |
| 2004 | $0.00 | $0.00 | $0.00 | 0.17B | 1.4% | — |
| 2003 | $0.00 | $0.00 | $0.00 | 0.17B | 12.9% | — |
| 2002 | $0.00 | $0.00 | $0.00 | 0.15B | 2.7% | — |
| 2001 | $0.00 | $0.00 | $0.00 | 0.15B | 1.7% | — |
| 2000 | $0.00 | $0.00 | $0.00 | 0.14B | — | — |
Cash buyback spend (USD) — annual & quarterly history
Trailing-twelve-month and per-period cash repurchases for CME Group (CME) from the consolidated cash flow statement (line: common stock repurchased), in USD as filed.
Cash buyback spend over time for CME Group (CME)
Per-period cash repurchases
Cash buyback spend annual + quarterly history for CME Group (CME)
| Fiscal year | Period ended | Reported | Buyback Spend | YoY | YoY change |
|---|---|---|---|---|---|
| 2025 | $266.10M | +706.4% | +$233.10M | ||
| 2024 | $33.00M | +54.2% | +$11.60M | ||
| 2023 | $21.40M | -13.7% | -$3.40M | ||
| 2022 | $24.80M | — | +$24.80M | ||
| 2021 | $0 | -100.0% | -$41.40M | ||
| 2020 | $41.40M | +12.5% | +$4.60M | ||
| 2019 | $36.80M | — | +$36.80M | ||
| 2018 | $0 | — | $0 | ||
| 2017 | $0 | — | $0 | ||
| 2016 | $0 | — | $0 | ||
| 2015 | $0 | — | $0 | ||
| 2014 | $0 | — | $0 | ||
| 2013 | $0 | — | $0 | ||
| 2012 | $0 | -100.0% | -$220.40M | ||
| 2011 | $220.40M | -61.7% | -$354.90M | ||
| 2010 | $575.30M | +2030.7% | +$548.30M | ||
| 2009 | $27.00M | -87.9% | -$197.03M | ||
| 2008 | $224.03M | -76.4% | -$725.31M | ||
| 2007 | $949.34M | — | +$949.34M | ||
| 2006 | $0 | — | $0 | ||
| 2005 | $0 | — | $0 | ||
| 2004 | $0 | — | $0 | ||
| 2003 | $0 | — | $0 | ||
| 2002 | $0 | — | $0 | ||
| 2001 | $0 | — | $0 | ||
| 2000 | $0 | — | — |
CME Group (CME) most recent annual buyback spend stands at $266.10M (2025) – surged 706.4% year-over-year.
CME Group buyback spend has grown for 2 consecutive years, with a +45.1% compound annual growth rate over 2020–2025 (5 years).
CME Group buyback spend plunged from $949.34M in 2007 to $266.10M in 2025, a 72.0% drawdown.
2007 marks the peak buyback spend at $949.34M, with the historical low of $0 recorded in 2000.
Among 8 Financial Services peers, CME Group (CME) ranks 8th; the peer median for buyback spend is $12.87B.
CME Group Buyback Spend 2025: $266.10M
CME Group buyback spend in 2025 was $266.10M, surged 706.4% from 2024.
CME Group Buyback Spend 2024: $33.00M
CME Group buyback spend in 2024 was $33.00M, surged 54.2% from 2023.
CME Group Buyback Spend 2023: $21.40M
CME Group buyback spend in 2023 was $21.40M, declined 13.7% below 2022.
CME Group Buyback Spend 2022: $24.80M
CME Group buyback spend in 2022 was $24.80M.
CME Group Buyback Spend 2021: $0
CME Group buyback spend in 2021 was $0.
See more financial history for CME Group (CME).
Sector peers by buyback spend
Companies in the same sector as CME Group, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| JPMorgan Chase (JPM) | $34.59B | Financial Services |
| Bank of America (BAC) | $21.43B | Financial Services |
| Wells Fargo (WFC) | $19.52B | Financial Services |
| Visa (V) | $13.39B | Financial Services |
| Goldman Sachs (GS) | $12.36B | Financial Services |
| Mastercard (MA) | $11.73B | Financial Services |
| Morgan Stanley (MS) | $5.83B | Financial Services |
| Berkshire Hathaway (BRK-B) | $0 | Financial Services |
Share count history
Diluted weighted-average shares drive the EPS denominator and per-share capital-return maths. A falling diluted share count means buybacks are outpacing dilution from stock-based compensation and option exercises.
Diluted vs basic shares (annual)
Year-over-year change in diluted shares
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Dividend & buyback yield over time
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Buybacks vs stock-based compensation
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 8.35×.
Capital allocation mix
How CME Group splits cash returned to shareholders between dividends and buybacks, plus the headroom on free cash flow that's still available for additional repurchases.
Buybacks vs dividends (share of cash returned)
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $266.10M (TTM FCF − TTM dividends, clamped at zero).
Data & methodology
Where do buyback, dividend and compensation figures come from?
Cash buyback spend (common stock repurchased), dividends paid and stock-based compensation come from CME Group's consolidated cash flow statements — quarterly 10-Q and annual 10-K SEC filings, in USD as reported.
How are diluted shares and yields calculated?
Diluted weighted-average share counts come from the income statement (EPS denominator). Trailing twelve-month (TTM) aggregates sum the four most recent reported quarters. Buyback and dividend yields divide TTM cash flows by market capitalisation at the latest quarter-end.
How is buyback capacity defined?
Capacity compares TTM repurchases to free cash flow after dividends: operating cash flow minus capital expenditure, minus dividends paid, versus actual buybacks over the same trailing window.
Is this investment advice?
No. Figures are for informational and educational use only. Past buybacks and dividends do not predict future returns.
Frequently asked questions
Does CME Group buy back its own stock?
Yes, CME Group (CME) has repurchased shares in recent periods. See the history table and charts on this page for amounts and trends.
How much does CME Group spend on share buybacks?
Trailing twelve months (TTM) buyback spend is about $796.60M (sum of the last four quarterly cash-flow periods in our data). Figures are illustrative; verify in filings.
What is CME Group's buyback yield?
TTM buyback yield is about 0.75% (TTM buyback spend divided by market cap at the latest quarter-end in our data).
What is CME Group's shareholder yield?
Shareholder yield combines dividend yield and buyback yield. For the latest period we show approximately 0.75% combined (TTM-based where available).
Is CME Group diluting shareholders?
Compare stock-based compensation (SBC) to buybacks in the chart above. Net effect varies by year; see annual buyback vs SBC bars and the history table.
How has CME Group's share count changed?
Diluted weighted average shares changed by about 0.5% over roughly five fiscal years (annual income statement data).
What is CME Group's buyback spend?
Latest reported buyback spend for CME Group (CME) is $796.60M (period ending March 31, 2026).
How has CME Group buyback spend changed year-over-year?
CME Group (CME) buyback spend changed +706.4% year-over-year on the latest annual filing.
What is the long-term growth rate of CME Group buyback spend?
CME Group (CME) buyback spend compound annual growth rate is +45.1% over the most recent 5 years available.
When did CME Group buyback spend hit its highest annual value?
CME Group buyback spend reached its highest annual value of $949.34M in 2007.
What was CME Group buyback spend in 2024?
CME Group (CME) buyback spend in 2024 was $33.00M.
What was CME Group buyback spend in 2025?
CME Group (CME) buyback spend in 2025 was $266.10M.
Explore more
CME Overview
Company profile, financial tools, and key metrics
CME Revenue Counter
Earns $214.31 every second. See per minute, hour, and day.
CME Earnings Counter
Earns $134.53 per second net profit. See per minute, hour, and day.
CME Economic Scale
Exceeds French Polynesia's GDP. Compare with world economies.
CME What If Invested
What if you had invested $1,000? See historical returns from any date.
CME How It Makes Money
Discover visual breakdown of $6.76B in revenue — where it comes from and where it goes.
CME Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
CME Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
CME Daily Price Character
Balanced · 52.4% historical win rate (green days). Streaks & record days.
CME Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.
CME Dividend Profile
Yield: 3.86%. Safety: 5/8. See full history.
CME Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
CME Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.
CME Dividend Capture
Historical pre-ex touch stats, gap distribution, after-tax calculator, and a backtest simulator (limit-order vs MOC exit).
CME Financials
Revenue, EPS, EBITDA, market cap, debt and balance sheet history with annual and quarterly data.